ホーム >> JKMA Guide >> English Guide >> The Future Vision for Kampo Medicines 2040 - Responsibility for People's Health and Healthcare -

The Future Vision for Kampo Medicines 2040 - Responsibility for People's Health and Healthcare -

　In May 2018, the Japanese government released the prospect for future social security in 2040. The report predicts that Japan's elderly population will peak in 2040. To contribute to people's health and healthcare in an aging society, for instance, extending healthy life expectancy by supplying Kampo products and others based on crude drugs, we have established "The Future Vision for Kampo Medicines 2040 - Responsibility for People's Health and Healthcare -."

Vision 1
We will accumulate scientific evidence under industry-government-academia cooperation and enhance the usefulness of Kampo products and others based on crude drugs in medical care.

  1. Accumulation of evidence

    2. 　　We will encourage the establishment of methods for evaluating usefulness, the scientific elucidation of shou that is the unique concept for Kampo, and medical economics research to contribute to the establishment of evidence-based medicine in Kampo treatment.
    In addition, we will contribute to the healthy lives of many patients by accumulating evidence of new uses, including supportive therapy in cancer treatment and medical care for frailty in the elderly.

  2. Inclusion of Kampo products and others based on crude drugs for ethical use in these practice guidelines

    3. 　　We contribute to expanding the range of treatment by accumulating evidence to increase formulations listed on treatment guidelines to allow many physicians to use Kampo products and others based on crude drugs.

  3. Securing of safety and promotion of proper use of Kampo products and others based on crude drugs

    4. 　　We at JKMA will independently prepare the materials for providing information about proper use of Kampo products and others based on crude drugs and will disseminate information to healthcare facilities and general users via our website and other media. We will continue to raise the value of Kampo products and others based on crude drugs as pharmaceutical products and will establish the usefulness in healthcare.

Vision 2
We will diligently try to procure the necessary quantity of crude drugs for Kampo preparations.

  1. Securing of necessary quantity of crude drugs for Kampo preparations

    2. 　　As for domestic cultivation, we will increase production about three times by solving many issues, for instance, securing seeds and seedlings, training cultivation technicians and instructors, founding processing/preparation facilities, and raising efficiency and ensuring continuity of production. Today, we import approximately 80% of crude drugs for Kampo preparations from China. In this context, we will try to maintain a favorable relationship with the country. In addition, we will increase sources to manage the risk of delayed procurement caused by natural calamities and abnormal weather.

  2. Promotion of cultivation of crude drugs for Kampo preparations

    3. 　　We will conduct a survey on the ratios of cultivated forms and wild forms of crude drugs to choose preferred items and promote cultivation without limiting production areas.

  3. Japan-China interchange for stable procurement of crude drugs for Kampo preparations

    4. 　　We are currently communicating with China and exchanging information. We will regularly interchange with China to maintain and develop a successful bilateral relationship and stably secure crude drugs for Kampo preparations.

Vision 3
We will strengthen the quality control process from crude drugs for Kampo preparations to finished products for the stable supply of quality Kampo products and others based on crude drugs.

  1. Assurance of quality of crude drugs for Kampo preparations

    2. 　　We will enhance surveillance and research on quality, including origin, properties, verification tests, and quantitative methods of crude drugs, and train the crude drug managers who play a key role in good manufacturing practices for Kampo to upgrade the level of quality control for crude drugs comprehensively.

  2. Assurance of quality in the process from crude drugs for Kampo preparations to final products, and stable supply

    3. 　　We will ensure thorough quality control with good manufacturing practices and voluntary standards as well as the stable supply of quality Kampo products and others based on crude drugs. Additionally, we will advocate familiarization with the JKMA version of GACP among farmers and assure quality in the safety in crude drugs for Kampo preparations, Kampo products and others based on crude drugs, for instance, controlling pesticide residue, heavy metal, and microorganisms.

  3. Response to ISO/TC 249

    4. 　　We will respond to ISO/TC 249 appropriately and use information on other ISO technical committees effectively by offering new suggestions and submitting opinions about the activities associated with the quality of crude drugs for Kampo preparations.

  4. Stable supply of Kampo products for ethical use

    5. 　　To continuously secure a stable supply of Kampo products and others based on crude drugs for ethical use, we will approach administrative bodies and related organizations.

Vision 4
We will expand the development of new dosage forms and research on additional indications of Kampo products for ethical use and support the establishment of guidelines for applications of pharmaceuticals containing multiple ingredients, such as Kampo products.

  1. Promotion of research on Kampo products and others based on crude drugs and the establishment of guidelines for applications for pharmaceuticals containing multiple ingredients

    2. 　　We will promote the development of new dosage forms and research on additional indications of Kampo products for ethical use. In addition, we will support the establishment of guidelines for applications for pharmaceuticals containing multiple ingredients.

Vision 5
We will boost the development of OTC Kampo products and crude drug products and enhance post-marketing information provision.

  1. Encouragement of self-medication

    2. 　　We will encourage self-medication through the development and fulfillment of OTC Kampo products that are made from crude drugs and crude drug products.

  2. Development of OTC Kampo products and crude drug products

    3. 　　The environment exists for approval of Kampo products and others based on crude drugs, for example, inclusion of more formulations in standards of approval. We will continue to advocate research and development of OTC Kampo products and crude drug products.

  3. Enhancement of provision of information on OTC Kampo products and crude drug products

    4. 　　We will enhance outreach activities for consumers by sharing actual cases of consultations with consumers and providing information and materials via lecture meetings and leaflets.

  4. Advertisements of OTC Kampo products and crude drug products

    5. 　　We will enhance the advertising functions in cooperation with the related organizations and promote the proper use of OTC Kampo products and crude drug products.

Vision 6
We will upgrade reliability by strengthening compliance as well as quality and safety control for Kampo products and others based on crude drugs in corporate members.

  1. Fortification of compliance activities

    2. 　　We will promote the construction and rearrangement of the compliance system and elevation of corporate ethics, and prevent corporate scandals to increase trust among people.

  2. Fortification of the three-key-role system

    3. 　　To facilitate the execution of jobs in the three key roles as defined in the laws and regulations, we will request that corporate members fortify the three-key-role system to upgrade reliability in quality and safety control for Kampo products and others based on crude drugs.

Vision 7
We will contribute to the conservation of the global environment and biological diversity, the protection of wild plants and animals, and will proactively work toward the international expansion of crude drugs that are natural blessings.

  1. Enhancement of eco-friendly activities

    2. 　　We will contribute to the achievement of a low carbon society, a recycling-based society, and a natural symbiosis society in consideration of global trends including the Paris Agreement and SDGs.

  2. Appropriate response to international treaties including the Convention on Biological Diversity

    3. 　　We will observe the domestic laws of the crude drug producing countries under the principles of the Convention on Biological Diversity and the Nagoya Protocol on Access and Benefit-sharing. We will observe the domestic laws relating to endangered species in accordance with CITES.

  3. Promotion of international expansion of Kampo products and others based on crude drugs

    4. 　　We will transmit the knowledge of Kampo products and others based on crude drugs from Japan to the world to contribute to the improvement of global public health and promote the international expansion of these products.

Vision 8
We will implement outreach activities and enhance collaboration with the related organizations, academic societies, research institutions, administrative bodies, and others.

  1. Provision of information to people and fulfillment of outreach activities

    2. 　　We will try to popularize Kampo by providing information to effectively raise awareness. Additionally, we will fulfill outreach activities to build trust through interactive dialogues with people.

  2. Enhancement of collaboration with academic societies and universities relating to crude drugs and Kampo

    3. 　　We will enhance collaboration with academic societies and universities related to crude drugs and will cooperate in human resource development, for example, organizing symposiums at academic meetings concerning crude drugs in the industry and proactively sending lecturers to special lectures about Kampo and crude drugs at universities.

  3. Enhancement of cooperation with the related organizations, academic societies, research institutions, administrative bodies, and others

    4. 　　We will enhance communications with the related organizations, academic societies, research institutions, administrative bodies, and others and solve issues under satisfactory cooperation promptly and properly.